Journal
AESTHETIC SURGERY JOURNAL
Volume 41, Issue -, Pages S69-S74Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/asj/sjab130
Keywords
-
Categories
Funding
- Suneva Medical, Inc. (San Diego, CA, USA)
- Allergan Aesthetics, an Abbvie Company (Irvine, CA, USA)
Ask authors/readers for more resources
Autologous fat grafting has a long history dating back to the late 19th century, with significant advancements in knowledge and techniques since then. Future directions in fat grafting may focus on optimizing current methods, expanding clinical indications, and selectively utilizing adipose graft components for various regenerative purposes.
One of the earliest reported cases of autologous fat grafting (AFG) was by Neuber in 1893 and consisted of the transfer of small lobules of fat from the upper arm for cicatrical depression of the face. He advocated the use of smaller grafts, noting that pieces larger than the size of a bean would form cysts. In 1895, Czerny excised a lumbar lipoma and transplanted it to the chest for breast reconstruction. Since these early reports, the knowledge base around AFG has expanded exponentially, as illustrated by the other papers within this special topic. As we embark on the next phase of AFG in the clinical setting, there are several directions which are near-clinical translation. This paper discusses future directions in fat grafting that build on optimization of our current techniques as clinical indications expand, such as supplementing purified lipoaspirate and the associated regulatory burden, or deconstructing adipose tissue to selectively use adipose graft components for a variety of regenerative indications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available